Similar Posts
Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Grayscale CEO Michael Sonnenshein on bitcoin ETF approval: The culmination of 10 years of work
Grayscale CEO Michael Sonnenshein joins ‘Squawk Box’ to discuss the SEC’s approval of bitcoin ETFs, the long road to regulatory approval, what it means for Grayscale and crypto at large going forward, and more.
Citi’s restructuring will work this time, says Wells Fargo’s Mike Mayo
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell Mike Mayo, Wells Fargo bank analyst, joins ‘Closing Bell’ to discuss Citi’s Q4 warning, his bank earning predictions, and more. 05:16 7 minutes ago
How to trade Costco ahead of next week’s earnings
The ‘Options Action’ traders talk Costco strategy ahead of earnings next week
The ‘last mile’ of disinflation is going to get a lot trickier, says Mohamed El-Erian
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Mohamed El-Erian, Allianz chief economic advisor and president of Queens’ College, Cambridge, joins ‘Squawk Box’ to discuss the latest market trends, what to expect from today’s December CPI data, the impact on the Fed’s rate path decision, and more.
With ‘meaningful overweight’ position in chip stocks, fund manager reveals his top picks
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Steven Glass of Pella Funds Management talks about the sectors that benefit from quantitative tightening and his top stock picks. 02:29 Tue, Mar 29 20224:02 AM EDT
